ARAY Accuray Incorporated
$0.14▲ +6.87%
Healthcare
Other
After hours
$0.13▼ -7.14%
Oct 29, 7:52 PM ET
Volume 1.22M
Avg Volume (10D) 2.16M
Key Metrics & Fundamentals
Market Cap
$16.72M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.12 - 1.46
% vs 50 MA
-38.33%
% vs 200 MA
-62.40%
RSI-14
33.3
MACD Histogram
+0.0000
Beta (1Y vs SPY)
2.67
Free Cash Flow
$1.07M
Gross Rev
$100.92M
Gross Profit
$35.08M
EBITDA
$6.59M
COGS
$65.84M
Operating Exp
$28.81M
Operating Income
$6.27M
EBIT
$6.27M
Pretax Income
-$1.51M
Net Income
-$1.94M
EPS (Diluted)
-0.02
Price & Volume History
Loading chart…
Recent News

Accuray to Report First Quarter Fiscal 2027 Financial Results on November 4, 2026
PR Newswire · Oct 21, 2026 4:05 PM ET

Accuray Announces Stockholder Approval of Key Financing-Related Proposals and Appointment of New Independent Director
PR Newswire · Oct 6, 2026 4:10 PM ET
BC-Most Active Stocks
Associated Press · Sep 28, 2026 10:30 AM ET

Accuray partners with Samsung NeuroLogica on CyberKnife imaging
Medical Device Network · Sep 28, 2026 4:10 AM ET

Accuray and Samsung NeuroLogica Advance Volumetric Imaging Collaboration for the Accuray CyberKnife® Platform
PR Newswire · Sep 27, 2026 11:15 AM ET

What Accuray’s (ARAY) $8 Million RaySearch Deal Means for Its Adaptive Therapy Push
Insider Monkey · Sep 14, 2026 4:03 PM ET
Accuray, RaySearch to Collaborate on Adaptive Radiation Therapy
MT Newswires · Sep 11, 2026 12:05 PM ET

Accuray and RaySearch Agree to Collaboration Integrating RayStation Software with Accuray Platforms to Accelerate Accuray's Online Adaptive Capabilities
PR Newswire · Sep 11, 2026 11:28 AM ET

Balance Sheet Rescue Meets China Drag in Accuray’s (ARAY) Mixed Quarter
Insider Monkey · Aug 28, 2026 5:31 PM ET

Accuray (ARAY) Q4 2026 Earnings Call Transcript
Motley Fool · Aug 26, 2026 5:30 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See ARAY's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.